LTBP2 promotes meningioma progression by enhancing glycolysis via the PI3K/AKT/mTOR/c-Myc signaling pathway

LTBP2 plays a critical role in meningioma progression by activating the PI3K/AKT and mTOR/c-Myc signaling pathways, highlighting its potential as a biomarker and therapeutic target.

Authors

Institutions

Publication Details

Journal
Discover Oncology
Published
2025-11-25
DOI
https://doi.org/10.1007/s12672-025-04005-w
Primary Topic
Meningioma and schwannoma management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

LTBP2 promotes meningioma progression by enhancing glycolysis via the PI3K/AKT/mTOR/c-Myc signaling pathway

Changqing Zhang, Xuemin Li
Discover Oncology
Meningioma and schwannoma management
article

LTBP2 promotes meningioma progression by enhancing glycolysis via the PI3K/AKT/mTOR/c-Myc signaling pathway

Changqing Zhang, Xuemin Li
article en

Abstract

LTBP2 plays a critical role in meningioma progression by activating the PI3K/AKT and mTOR/c-Myc signaling pathways, highlighting its potential as a biomarker and therapeutic target.

Discover OncologyVol. 16(1)
Shanghai University of Traditional Chinese Medicine (CN), Shanxi Province Hospital of Traditional Chinese Medicine (CN), Shanghai Traditional Chinese Medicine Hospital (CN)
Openalex Percentile: Top 53%
Meningioma and schwannoma management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.